eRaDicate
The project “eRaDicate” is an EU-supported Horizon-Europe Marie Sklodowska-Curie Doctoral-Network (DN) offering an international, multi- & interdisciplinary as well as inter-sectoral training, research and development programme in the cancer field. The scientific aims of eRaDicate are for the doctoral candidates to test novel nuclear-receptor targeting drugs as anti-cancer agents, such as the retinoic acid receptor (RAR) and the vitamin D receptor (VDR) using a variety of molecular biology and biochemical methods, as well as bioinformatics approaches. The project was launched at the kick-off meeting at TissueGnostics in Vienna from the 7. to 9.2.2024.